Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection.

Herrera AL, Faal H, Moss D, Addengast L, Fanta L, Eyster K, Huber VC, Chaussee MS.

Sci Rep. 2018 Aug 14;8(1):12126. doi: 10.1038/s41598-018-29714-x.

2.

Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Klonoski JM, Watson T, Bickett TE, Svendsen JM, Gau TJ, Britt A, Nelson JT, Schlenker EH, Chaussee MS, Rynda-Apple A, Huber VC.

Viral Immunol. 2018 Jul/Aug;31(6):457-469. doi: 10.1089/vim.2017.0193. Epub 2018 Jun 5.

3.

Binding host proteins to the M protein contributes to the mortality associated with influenza-Streptococcus pyogenes superinfections.

Herrera AL, Suso K, Allison S, Simon A, Schlenker E, Huber VC, Chaussee MS.

Microbiology. 2017 Oct;163(10):1445-1456. doi: 10.1099/mic.0.000532.

4.

The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Herrera AL, Huber VC, Chaussee MS.

Front Microbiol. 2016 Mar 21;7:342. doi: 10.3389/fmicb.2016.00342. eCollection 2016. Review.

5.

The Streptococcal Proteome.

Callegari EA, Chaussee MS.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

6.

Inactivation of the Rgg2 transcriptional regulator ablates the virulence of Streptococcus pyogenes.

Zutkis AA, Anbalagan S, Chaussee MS, Dmitriev AV.

PLoS One. 2014 Dec 8;9(12):e114784. doi: 10.1371/journal.pone.0114784. eCollection 2014.

7.

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Klonoski JM, Hurtig HR, Juber BA, Schuneman MJ, Bickett TE, Svendsen JM, Burum B, Penfound TA, Sereda G, Dale JB, Chaussee MS, Huber VC.

Vaccine. 2014 Sep 8;32(40):5241-9. doi: 10.1016/j.vaccine.2014.06.093. Epub 2014 Jul 29.

8.

Transcriptional regulation of a bacteriophage encoded extracellular DNase (Spd-3) by Rgg in Streptococcus pyogenes.

Anbalagan S, Chaussee MS.

PLoS One. 2013 Apr 17;8(4):e61312. doi: 10.1371/journal.pone.0061312. Print 2013.

9.

CodY-mediated regulation of Streptococcus pyogenes exoproteins.

McDowell EJ, Callegari EA, Malke H, Chaussee MS.

BMC Microbiol. 2012 Jun 21;12:114. doi: 10.1186/1471-2180-12-114.

10.

Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.

Anbalagan S, Dmitriev A, McShan WM, Dunman PM, Chaussee MS.

J Bacteriol. 2012 Aug;194(15):3961-71. doi: 10.1128/JB.06709-11. Epub 2012 May 25.

11.

Identification of Rgg binding sites in the Streptococcus pyogenes chromosome.

Anbalagan S, McShan WM, Dunman PM, Chaussee MS.

J Bacteriol. 2011 Sep;193(18):4933-42. doi: 10.1128/JB.00429-11. Epub 2011 Jul 15.

12.

Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Chaussee MS, Sandbulte HR, Schuneman MJ, Depaula FP, Addengast LA, Schlenker EH, Huber VC.

Vaccine. 2011 May 12;29(21):3773-81. doi: 10.1016/j.vaccine.2011.03.031. Epub 2011 Apr 8.

13.

The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Dmitriev AV, Chaussee MS.

Future Microbiol. 2010 Oct;5(10):1539-51. doi: 10.2217/fmb.10.116. Review.

14.

Community-based intervention to manage an outbreak of MRSA skin infections in a county jail.

Elias AF, Chaussee MS, McDowell EJ, Huntington MK.

J Correct Health Care. 2010 Jul;16(3):205-15. doi: 10.1177/1078345810366679. Epub 2010 May 12.

15.

Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Gao X, Wan F, Mateo K, Callegari E, Wang D, Deng W, Puente J, Li F, Chaussee MS, Finlay BB, Lenardo MJ, Hardwidge PR.

PLoS Pathog. 2009 Dec;5(12):e1000708. doi: 10.1371/journal.ppat.1000708. Epub 2009 Dec 24.

16.

A naturally occurring Rgg variant in serotype M3 Streptococcus pyogenes does not activate speB expression due to altered specificity of DNA binding.

Kappeler KV, Anbalagan S, Dmitriev AV, McDowell EJ, Neely MN, Chaussee MS.

Infect Immun. 2009 Dec;77(12):5411-7. doi: 10.1128/IAI.00373-09. Epub 2009 Sep 14.

17.

Inter- and intraserotypic variation in the Streptococcus pyogenes Rgg regulon.

Dmitriev AV, McDowell EJ, Chaussee MS.

FEMS Microbiol Lett. 2008 Jul;284(1):43-51. doi: 10.1111/j.1574-6968.2008.01171.x.

18.

Proteomic analysis of proteins secreted by Streptococcus pyogenes.

Chaussee MA, McDowell EJ, Chaussee MS.

Methods Mol Biol. 2008;431:15-24.

PMID:
18287744
19.

Growth phase-associated changes in the transcriptome and proteome of Streptococcus pyogenes.

Chaussee MA, Dmitriev AV, Callegari EA, Chaussee MS.

Arch Microbiol. 2008 Jan;189(1):27-41. Epub 2007 Jul 31.

PMID:
17665172
20.
21.

Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB.

Reid SD, Chaussee MS, Doern CD, Chaussee MA, Montgomery AG, Sturdevant DE, Musser JM.

FEMS Immunol Med Microbiol. 2006 Nov;48(2):283-92. Epub 2006 Sep 25.

22.

Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes.

Chaussee MA, McDowell EJ, Rieck LD, Callegari EA, Chaussee MS.

J Antimicrob Chemother. 2006 Oct;58(4):752-9. Epub 2006 Aug 5.

PMID:
16891633
23.

Persistence of Streptococcus pyogenes in stationary-phase cultures.

Wood DN, Chaussee MA, Chaussee MS, Buttaro BA.

J Bacteriol. 2005 May;187(10):3319-28.

24.
25.

Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes.

Chaussee MS, Somerville GA, Reitzer L, Musser JM.

J Bacteriol. 2003 Oct;185(20):6016-24.

26.

Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival.

Somerville GA, Chaussee MS, Morgan CI, Fitzgerald JR, Dorward DW, Reitzer LJ, Musser JM.

Infect Immun. 2002 Nov;70(11):6373-82.

27.

Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks.

Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, Sturdevant DE, Ricklefs SM, Porcella SF, Parkins LD, Beres SB, Campbell DS, Smith TM, Zhang Q, Kapur V, Daly JA, Veasy LG, Musser JM.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4668-73. Epub 2002 Mar 26.

28.

Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes.

Chaussee MS, Sylva GL, Sturdevant DE, Smoot LM, Graham MR, Watson RO, Musser JM.

Infect Immun. 2002 Feb;70(2):762-70.

29.

Identification of Rgg-regulated exoproteins of Streptococcus pyogenes.

Chaussee MS, Watson RO, Smoot JC, Musser JM.

Infect Immun. 2001 Feb;69(2):822-31.

31.

The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production.

Chaussee MS, Ajdic D, Ferretti JJ.

Infect Immun. 1999 Apr;67(4):1715-22.

32.
33.
34.
35.

Effects of environmental factors on streptococcal erythrogenic toxin A (SPE A) production by Streptococcus pyogenes.

Chaussee MS, Liu J, Stevens DL, Ferretti JJ.

Adv Exp Med Biol. 1997;418:551-4. No abstract available.

PMID:
9331711
36.

Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections.

Chaussee MS, Liu J, Stevens DL, Ferretti JJ.

J Infect Dis. 1996 Apr;173(4):901-8.

PMID:
8603969
37.

Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes.

Chaussee MS, Gerlach D, Yu CE, Ferretti JJ.

Infect Immun. 1993 Sep;61(9):3719-23.

Supplemental Content

Loading ...
Support Center